Rational Design of Small Molecule Inhibitors Targeting the Ras GEF, SOS1

• Translation of the mechanism of Ras regulation into a Ras-targeting approach
• Structure-based rational design of small-molecule inhibitors of SOS1
• A proof of principle of inhibiting the catalytic activity of the Ras GEF, SOS1
• Lead chemical inhibitors as useful tools against Rasopathies

SummaryRas GTPases regulate intracellular signaling involved in cell proliferation. Elevated Ras signaling activity has been associated with human cancers. Ras activation is catalyzed by guanine nucleotide exchange factors (GEFs), of which SOS1 is a major member that transduces receptor tyrosine kinase signaling to Ras. We have developed a rational approach coupling virtual screening with experimental screening in identifying small-molecule inhibitors targeting the catalytic site of SOS1 and SOS1-regulated Ras activity. A lead inhibitor, NSC-658497, was found to bind to SOS1, competitively suppress SOS1-Ras interaction, and dose-dependently inhibit SOS1 GEF activity. Mutagenesis and structure-activity relationship studies map the NSC-658497 site of action to the SOS1 catalytic site, and define the chemical moieties in the inhibitor essential for the activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation. These studies establish a proof of principle for rational design of small-molecule inhibitors targeting Ras GEF enzymatic activity.

Graphical AbstractFigure optionsDownload high-quality image (348 K)Download as PowerPoint slide